20iu ghk cu GHK‑Cu Copper Peptide Therapy GHK-Cu Copper Peptide | Skin

The parent protein was first isolated in the 1990s by a Croatian research group led by Dionis Sikiric, who would go on to publish the majority of foundational BPC-157 studies

Compounded medications are prepared under provider supervision and are not FDA-approved to treat, cure, or prevent disease.

The highest dose of 4.5 mg produced an average weight loss of 11.5 kg, roughly 25 pounds, in just 26 weeks

This guide from the team at Elon Health Urgent Care in Davenport, FL covers the mild side effects, the rare risks, and who should talk with a provider first

Disclosure: this links to a paid resource we created

Tests in bacteria, cells, and mice all came back negative, suggesting the compound does not pose carcinogenic risk through DNA damage mechanisms